Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers

🔗 Access full article via JAMA Oncology

This nonrandomized clinical trial examines the clinical activity and adverse events of a novel combination treatment for advanced human papillomavirus–associated cancers.